Company Number: 14869730

Analysis Date: 2025-07-20 18:46 UTC

1. Credit Opinion: DECLINE
   THENOAH LTD is a newly incorporated entity with only one financial year reported. The company shows negative net assets (£-198) and negative working capital (£-198), indicating a weak balance sheet and insufficient current assets to cover short-term liabilities. The absence of turnover and operating cash flow data further clouds the ability to assess its debt servicing capability. Given the minimal capitalization (only £1 share capital) and negative equity, the company currently lacks financial resilience and is not recommended for credit extension without significant additional information or guarantees.

2. Financial Strength:
   The balance sheet at 31 May 2024 reveals a fragile financial position. Current assets consist solely of £475 in cash, with current liabilities of £673, resulting in a net current liability position. There are no fixed assets or other financial resources to support operations or absorb losses. Shareholders’ funds are negative at £-198, driven by accumulated losses since incorporation. The company’s financial structure does not provide a buffer against unforeseen expenses or economic downturns.

3. Cash Flow Assessment:
   Cash on hand is minimal at £475, insufficient to cover current liabilities of £673. The lack of reported turnover or operating income suggests no meaningful cash inflows from business operations to support working capital needs. No evidence of external financing or credit lines is presented. The negative working capital position indicates potential liquidity stress, raising concerns about the company’s ability to meet immediate obligations without additional capital injection.

4. Monitoring Points:

• Monitor future turnover and profitability to assess operational viability.
• Track cash flow statements for signs of improving liquidity or continued cash burn.
• Watch for increases in current liabilities or overdue payments indicating payment difficulties.
• Review any capital injections or shareholder loans that could improve net asset position.
• Confirm timely filing of subsequent accounts and confirmation statements to maintain regulatory compliance.